Уноси
Search full-text
"P Miranda"
-
Descriptors for Apple Genetic Resources (2022)
M. Lateur, E. Dapena, D. Szalatnay, A. Gantar, A. Guyader, I. Hjalmarsson, M. Hofer, L. Ikase, M. Kellerhals, G. Lacis, I. Militaru, C. Miranda Jimenez, G. Osterec, J. Rey, A. Rondia, K. Volens, M. Kajkut Zeljković, M. Ordidge, Descriptors for Apple Genetic Resources, European Cooperative Programme for Plant Genetic Resources, Rome, Italy, 2022 -
ECPGR Characterization and Evaluation Descriptors for Pear Genetic Resources - Pear (Pyrus communis) (2022)
M. Lateur, D. Szalatnay, M. Hofer, M. Bergamaschi, A. Guyader, I. Hjalmarsson, I. Militaru, C. Miranda Jimenez, G. Osterec, A. Rondia, T. Sotiropoulos, M. Kajkut Zeljković, M. Ordidge, ECPGR Characterization and Evaluation Descriptors for Pear Genetic Resources - Pear (Pyrus communis), pp. 1 - 48, European Cooperative Programme for Plant Genetic Resources, Rome, Italy, 2022 -
A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study (2013-05)
D. Yoo, P. Hrycaj, P. Miranda, E. Ramiterre, M. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, A randomised,double-blind,parallel-group study to dmostrate eqivalence in afficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis:The PLANETRA study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, May, 2013 -
FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis (2014)
D. Yoo, P. Hrycaj, P. Miranda, E. Piotrowski, S. Shevchuk, V. Kovalenko, N. Prodanović, M. Abello-Banfi, S. Gutierrez-Ureña, L. Morales-Olazabal, M. Tee, R. Jimenez, O. Zamani, S. Lee, H. Kim, W. Park, U. Müller-Ladner, FRI0143 A radomized, double-blind, phase 3 study demonstrates clinical equivalence od CT-P13 to ifliximab when co-administered with methotrexate in patients with active rheumatoid arthritis, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2014 -
Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study (2016)
D. Yoo, N. Prodanović, J. Jaworski, P. Miranda, E. Ramiterre, A. Lanzon, A. Baranauskaite, P. Wiland, C. Abud-Mendoza, B. Oparanov, S. Smiyan, H. Kim, S. Lee, S. Kim, W. Park, Efficacy and safety of CT- P13 (biosimilar infliximab) in patients with rheumatoid arthritis :Comparison betwen switching from reference infliximab to CT-P13 and continuing CT- P13 in the PLANETRA extension study, ANNALS OF THE RHEUMATIC DISEASES, pp. 10 - 10, 2016 -
Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
C. Hee Suh, A. Berrocal Kasay, E. Chalouhi El-Khouri, P. Miranda, LJ. Božić, S. Jeka, P. Hrycaj, D. Rekalov, P. Wiland, A. Krause, I. Szombati, A. Mihailova, I. Hospodarskyy, M. Piotrowski, S. Ryul Kwon, E. Young Lee, D. Hyun Yoo, W. Park, S. Cheol Shim, S. Joon Lee, T. S. Kwon, Pharmacokinetics and Safety of Three Formulations of Rituximab (CT-P10, US-sourced Innovator Rituximab and EU-sourced Innovator Rituximab) in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016 -
Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks (2016-09)
W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. Chalouhi El-Khouri, F. Irazoque-Palazuelos, F. Fidencio Cons Molina, P. Shesternya, P. Miranda, F. G. Medina-Rodriguez, P. Wiland, S. Jeka, J. Chavez-Corrales, O. Garmish, T. Linde, D. Rekalov, P. Hrycaj, A. Krause, N. Fomina, O. Piura, M. Abello-Banfi, C. Hee Suh, S. Cheol Shim, S. Joon Lee, S. Young Lee, S. Hwan Kim, D. Hyun Yoo, Efficacy and Safety of CT-P10, Rituximab Biosimilar Candidate, and Innovator Rituximab in Patients with Rheumatoid Arthritis: Results from Phase 3 Randomized Controlled Trial over 24 Weeks, STED Journal, pp. 100 - 101, Sep, 2016 -
Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018-01)
T. Bochenek, V. Abilova, A. Alkan, B. Asanin, I. Beriain, Z. Besovic, P. Vella Bonanno, A. Bucsics, M. Davidescu, E. de Weerdt, N. Duborija-Kovacevic, J. Furst, M. Gaga, E. Gailite, J. Gulbinovic, E. Gurpinar, B. Hanko, V. Hargaden, T. Hotvedt, I. Hoxha, I. Huys, A. Inotai, A. Jakupi, H. Jenzer, R. Joppi, O. Laius, M. Lenormand, D. Makridaki, A. Malaj, K. Margus, V. Marković Peković, N. Miljkovic, J. de Miranda, S. Primozic, D. Rajinac, D. schwartz, R. Sebesta, S. Simoens, J. Slaby, L. Sović-Brkičić, T. Tesar, L. Tzirnis, E. Warminska, B. Godman, Systematic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries, Frontiers in Pharmacology, Vol. 8, No. article 942, pp. 1 - 23, Jan, 2018 -
Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial (2018-08)
W. Park, LJ. Božić, D. Milakovic, A. Berrocal Kasay, E. El-Khouri, F. Irazoque-Palazuelos, F. Molina, P. Shesternya, P. Miranda, F. Medina-Rodriguez, Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial, STED Journal, pp. 934 - 943, Aug, 2018 -
Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial (2019-06)
S. Cheol Shim, LJ. Božić, A. Berrocal Kasay, E. Chalouhi El-Khouri, F. Irazoque-Palazuelos, F. Fidencio Cons Molina, F. G Medina-Rodriguez, P. Miranda, P. Shesternya, J. Chavez-Corrales, P. Wiland, S. Jeka, O. Garmish, P. Hrycaj, N. Fomina, W. Park, C. Hee Suh, S. Joon Lee, S. Young Lee, Y. Ju Bae, D. Hyun Yoo, Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial, RHEUMATOLOGY, pp. 2193 - 2202, Jun, 2019 -
Patients perspectives on drug shortages in six European hospital settings – a cross sectional study (2021)
Kuruc Poje D, Kifer D, Huys I, Miranda J, Jenzer H, Miljković N, Hoppe- Tichy T, Bochniarz M, Frotini R, Schwartz D, Vujić- Aleksić V, Nezic L, Rinaki E, Tzimis L, Green K, Jovanic J, Caric B, Mandic D, Vilic K, Bochenek T, Baciv Vrca V, Marusic S, Patients perspectives on drug shortages in six European hospital settings – a cross sectional study, BMC HEALTH SERVICES RESEARCH, pp. 1 - 10, 2021 -
Patients perspectives on drug shortages in six European hospital settings – a cross sectional study (2021-07)
D. Kuruc Poje, D. Kifer, I. Huys, J. Miranda, H. Jenzer, N. Miljković, T. Hoppe-Tichy, M. Bochniarz, R. Frontini, D. Schwartz, V. Vujić-Aleksić, L. Nežić, E. Rinaki, L. Tzimis, T. Green, J. Jovanić, B. Carić, D. Mandić, K. Vilić, T. Bochenek, V. Bačić Vrca, S. Marušić, Patients perspectives on drug shortages in six European hospital settings – a cross sectional study, BMC HEALTH SERVICES RESEARCH, Vol. 21, No. 689, Jul, 2021 -
"Prizivanje okomitog okeana: ekopoetičke ekspedicije u poeziji Margaret Atwood" (2023)
T. Bijelić, "Prizivanje okomitog okeana: ekopoetičke ekspedicije u poeziji Margaret Atwood", Ekokritika: između prirode i kulture (ur. Goran Đurđević, Miranda Levanat Peričić i Suzana Marjanić), Sveučilište u Zadru, Zadar, 2023 -
Koncentracija K i Na u tkivu Phragmites communis Trin. Typha latifolia L., i Typha angustifolia L. na području Bardače (2010)
T. Maksimović, S. Lolić, B. Lubarda, M. Baltić, Koncentracija K i Na u tkivu Phragmites communis Trin. Typha latifolia L., i Typha angustifolia L. na području Bardače, 2010